Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo

Keyphrases

• Gene Vector 100%
• HIV-1 Tat 100%
• TAT Peptide 100%
• Solid Lipid Nanoparticles 100%
• Tat2 87%
• Gene Expression 37%
• DNA Degradation 37%
• Polyethylenimine 25%
• Innovative Device 12%
• Lung 12%
• Large Animal Model 12%
• Gene Transfer 12%
• Gene Delivery 12%
• Mouse in Vivo 12%
• Sequence-dependent 12%
• Plasmid DNA (pDNA) 12%
• Agarose Gel Electrophoresis 12%
• Intratracheal Instillation 12%
• Bronchial Epithelial Cells 12%
• Nanoparticle Preparation 12%
• Polyarginine 12%
• Aerosol Application 12%
• Precompaction 12%
• Jet Nebulization 12%
• Vibrating Membrane 12%
• In Vivo Applications 12%

Biochemistry, Genetics and Molecular Biology

• Human Immunodeficiency Virus 1 100%
• Gene Vector 100%
• Lipid Nanoparticles 100%
• Gene Expression 37%
• DNA Degradation 37%
• Nebulization 25%
• Animal Model 12%
• Gene Targeting 12%
• Transfection 12%
• Plasmid 12%
• in Vitro Gene Transfer 12%
• Arginine 12%
• Agarose Gel Electrophoresis 12%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Solid Lipid Nanoparticle 100%
• Polyethyleneimine 25%
• Gene Delivery 25%
• Plasmid DNA 12%
• Agarose Gel Electrophoresis 12%
• Polyarginine 12%